[
    "{\"step_by_step_thinking\": \"Isradipine is a calcium channel blocker that is commonly used to treat high blood pressure. However, there have been studies investigating its potential use in slowing the progression of early Parkinson's disease. One such study is the STEADY-PD III trial, which was a randomized, double-blind, placebo-controlled trial. The results of this trial showed that Isradipine did not significantly slow the progression of early Parkinson's disease compared to placebo. Therefore, the answer to the question is B. no.\", \"answer_choice\": \"B\"}"
]